629 related articles for article (PubMed ID: 9311920)
21. Hyperleptinemia in A(y)/a mice upregulates arcuate cocaine- and amphetamine-regulated transcript expression.
Tsuruta Y; Yoshimatsu H; Hidaka S; Kondou S; Okamoto K; Sakata T
Am J Physiol Endocrinol Metab; 2002 Apr; 282(4):E967-73. PubMed ID: 11882520
[TBL] [Abstract][Full Text] [Related]
22. Molecular interaction of Agouti protein and Agouti-related protein with human melanocortin receptors.
Tota MR; Smith TS; Mao C; MacNeil T; Mosley RT; Van der Ploeg LH; Fong TM
Biochemistry; 1999 Jan; 38(3):897-904. PubMed ID: 9893984
[TBL] [Abstract][Full Text] [Related]
23. Characterization of Agouti-related protein binding to melanocortin receptors.
Yang YK; Thompson DA; Dickinson CJ; Wilken J; Barsh GS; Kent SB; Gantz I
Mol Endocrinol; 1999 Jan; 13(1):148-55. PubMed ID: 9892020
[TBL] [Abstract][Full Text] [Related]
24. Molecular determination of agouti-related protein binding to human melanocortin-4 receptor.
Yang Y; Chen M; Lai Y; Gantz I; Yagmurlu A; Georgeson KE; Harmon CM
Mol Pharmacol; 2003 Jul; 64(1):94-103. PubMed ID: 12815165
[TBL] [Abstract][Full Text] [Related]
25. The role of agouti-related protein in regulating body weight.
Wilson BD; Ollmann MM; Barsh GS
Mol Med Today; 1999 Jun; 5(6):250-6. PubMed ID: 10366820
[TBL] [Abstract][Full Text] [Related]
26. Response of melanocortin-4 receptor-deficient mice to anorectic and orexigenic peptides.
Marsh DJ; Hollopeter G; Huszar D; Laufer R; Yagaloff KA; Fisher SL; Burn P; Palmiter RD
Nat Genet; 1999 Jan; 21(1):119-22. PubMed ID: 9916804
[TBL] [Abstract][Full Text] [Related]
27. Peripherally administered [Nle4,D-Phe7]-alpha-melanocyte stimulating hormone increases resting metabolic rate, while peripheral agouti-related protein has no effect, in wild type C57BL/6 and ob/ob mice.
Hoggard N; Rayner DV; Johnston SL; Speakman JR
J Mol Endocrinol; 2004 Dec; 33(3):693-703. PubMed ID: 15591028
[TBL] [Abstract][Full Text] [Related]
28. Inverse agonism gains weight.
Adan RA; Kas MJ
Trends Pharmacol Sci; 2003 Jun; 24(6):315-21. PubMed ID: 12823958
[TBL] [Abstract][Full Text] [Related]
29. Agouti antagonism of melanocortin-4 receptor: greater effect with desacetyl-alpha-melanocyte-stimulating hormone (MSH) than with alpha-MSH.
Mountjoy KG; Willard DH; Wilkison WO
Endocrinology; 1999 May; 140(5):2167-72. PubMed ID: 10218968
[TBL] [Abstract][Full Text] [Related]
30. An agouti mutation lacking the basic domain induces yellow pigmentation but not obesity in transgenic mice.
Miltenberger RJ; Mynatt RL; Bruce BD; Wilkison WO; Woychik RP; Michaud EJ
Proc Natl Acad Sci U S A; 1999 Jul; 96(15):8579-84. PubMed ID: 10411918
[TBL] [Abstract][Full Text] [Related]
31. Pre-obese and obese agouti mice are sensitive to the anorectic effects of peptide YY(3-36) but resistant to ghrelin.
Martin NM; Small CJ; Sajedi A; Patterson M; Ghatei MA; Bloom SR
Int J Obes Relat Metab Disord; 2004 Jul; 28(7):886-93. PubMed ID: 15148507
[TBL] [Abstract][Full Text] [Related]
32. Agouti regulation of intracellular calcium: role of melanocortin receptors.
Kim JH; Kiefer LL; Woychik RP; Wilkison WO; Truesdale A; Ittoop O; Willard D; Nichols J; Zemel MB
Am J Physiol; 1997 Mar; 272(3 Pt 1):E379-84. PubMed ID: 9124542
[TBL] [Abstract][Full Text] [Related]
33. Loops and links: structural insights into the remarkable function of the agouti-related protein.
Millhauser GL; McNulty JC; Jackson PJ; Thompson DA; Barsh GS; Gantz I
Ann N Y Acad Sci; 2003 Jun; 994():27-35. PubMed ID: 12851295
[TBL] [Abstract][Full Text] [Related]
34. Anatomy of an endogenous antagonist: relationship between Agouti-related protein and proopiomelanocortin in brain.
Bagnol D; Lu XY; Kaelin CB; Day HE; Ollmann M; Gantz I; Akil H; Barsh GS; Watson SJ
J Neurosci; 1999 Sep; 19(18):RC26. PubMed ID: 10479719
[TBL] [Abstract][Full Text] [Related]
35. A synthetic human Agouti-related protein-(83-132)-NH2 fragment is a potent inhibitor of melanocortin receptor function.
Quillan JM; Sadée W; Wei ET; Jimenez C; Ji L; Chang JK
FEBS Lett; 1998 May; 428(1-2):59-62. PubMed ID: 9645475
[TBL] [Abstract][Full Text] [Related]
36. Induction of neuropeptide Y gene expression in the dorsal medial hypothalamic nucleus in two models of the agouti obesity syndrome.
Kesterson RA; Huszar D; Lynch CA; Simerly RB; Cone RD
Mol Endocrinol; 1997 May; 11(5):630-7. PubMed ID: 9139806
[TBL] [Abstract][Full Text] [Related]
37. Agouti-related protein has an inhibitory paracrine role in the rat adrenal gland.
Dhillo WS; Small CJ; Gardiner JV; Bewick GA; Whitworth EJ; Jethwa PH; Seal LJ; Ghatei MA; Hinson JP; Bloom SR
Biochem Biophys Res Commun; 2003 Jan; 301(1):102-7. PubMed ID: 12535647
[TBL] [Abstract][Full Text] [Related]
38. Mutations in the carboxyl terminus of the agouti protein decrease agouti inhibition of ligand binding to the melanocortin receptors.
Kiefer LL; Ittoop OR; Bunce K; Truesdale AT; Willard DH; Nichols JS; Blanchard SG; Mountjoy K; Chen WJ; Wilkison WO
Biochemistry; 1997 Feb; 36(8):2084-90. PubMed ID: 9047307
[TBL] [Abstract][Full Text] [Related]
39. Biased signaling initiated by agouti-related peptide through human melanocortin-3 and -4 receptors.
Yang Z; Tao YX
Biochim Biophys Acta; 2016 Sep; 1862(9):1485-94. PubMed ID: 27208795
[TBL] [Abstract][Full Text] [Related]
40. High-resolution NMR structure of the chemically-synthesized melanocortin receptor binding domain AGRP(87-132) of the agouti-related protein.
McNulty JC; Thompson DA; Bolin KA; Wilken J; Barsh GS; Millhauser GL
Biochemistry; 2001 Dec; 40(51):15520-7. PubMed ID: 11747427
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
